-
Mashup Score: 4Heart Failure Reviews - 4 hour(s) ago
Heart Failure Reviews is an international journal dedicated to the interdisciplinary dialogue on heart failure and its treatment. Publishes papers in both …
Source: link.springer.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 42Physician-Reported Reasons for Not Initiating Guideline-Directed Medical Therapy for Heart Failure: - 3 month(s) ago
Duke Clinical Research Institute, Durham, North Carolina, USA Duke University School of Medicine, Durham, North Carolina, USA. Twitter: @SJGreene_md, @DCRINews. Merck & Co, Inc, Rahway, New Jersey, USA Adelphi Real World, Bollington, United Kingdom Adelphi Real World, Bollington, United Kingdom Adelphi Real World, Bollington, United Kingdom Merck & Co, Inc, Rahway, New Jersey, USA Copyright © 2024, American College of Cardiology Foundation. Published by Elsevier Published online September 18,
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
Clinical inertia = dominant reason why we have widespread underuse of branded & unbranded lifesaving #GDMTs for #HFrEF, despite patients being medically eligible Delays/Omissions in #GDMTworks = preventable ☠️ &🏥 @gcfmd @ShelleyZieroth @DCRINews https://t.co/u7nmNKP6CV https://t.co/5wrZmpYQgA https://t.co/h6Dagv1daS
-
-
Mashup Score: 1
Nature Medicine – In a multicenter, open-label, randomized controlled trial, digital consults including digital data sharing, patient e-learning and guideline recommendations to clinicians improved…
Source: www.nature.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 51Heart Failure Medical Therapy Score and Clinical Outcomes - 4 month(s) ago
This cohort study investigates associations between a composite score for guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction at the time of discharge and clinical outcomes and costs.
Source: jamanetwork.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 115Physician-Reported Reasons for Not Initiating Guideline-Directed Medical Therapy for Heart Failure: - 5 month(s) ago
Duke Clinical Research Institute, Durham, North Carolina, USA Duke University School of Medicine, Durham, North Carolina, USA. Twitter: @SJGreene_md, @DCRINews. Merck & Co, Inc, Rahway, New Jersey, USA Adelphi Real World, Bollington, United Kingdom Adelphi Real World, Bollington, United Kingdom Adelphi Real World, Bollington, United Kingdom Merck & Co, Inc, Rahway, New Jersey, USA Copyright © 2024, American Col lege of Cardiology Foundation. Published by Elsevier Published online September 18,
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 112Rapid and Intensive Guideline-Directed Medical Therapy for Heart Failure: 5 Core Principles | Circulation - 6 month(s) ago
View all available purchase options and get full access to this article. Mebazaa, A, Davison, B, Chioncel, O, Cohen-Solal, A, Diaz, R, Filippatos, G, Metra, M, Ponikowski, P, Sliwa, K, Voors, AA, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet. 2022;400:1938–1952. doi: 10.1016/S0140-6736(22)02076-1 Rao, VN, Murray, E, Butler, J, Cooper, LB, Cox, ZL, Fiuzat, M,
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 111Rapid and Intensive Guideline-Directed Medical Therapy for Heart Failure: 5 Core Principles | Circulation - 6 month(s) ago
View all available purchase options and get full access to this article. Mebazaa, A, Davison, B, Chioncel, O, Cohen-Solal, A, Diaz, R, Filippatos, G, Metra, M, Ponikowski, P, Sliwa, K, Voors, AA, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet. 2022;400:1938–1952. doi: 10.1016/S0140-6736(22)02076-1 Rao, VN, Murray, E, Butler, J, Cooper, LB, Cox, ZL, Fiuzat, M,
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1
Listen to this episode from Don’t Miss a Beat on Spotify. Brendon Neuen, MBBS, PhD, joins hosts to discuss the landmark FLOW trial and its implications on the future of chronic kidney disease management as well as other compelling data surrounding semaglutide from the 61st European Renal Association Congress.
Source: open.spotify.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 34Cause-Specific Healthcare Costs Following Hospitalization for Heart Failure and Cost Offset with SGLT2 Inhibitor Therapy: - 8 month(s) ago
ABSTRACTBackgroundLittle is known regarding differences in cause-specific costs between HF with EF≤40% versus >40%, and potential cost implications of SGLT2i therapy.ObjectivesTo compare cause-spec…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
Congratulations to @vkittipibul on #ACC24 #SimPub now in @JACCJournals #JACCHF Cause-Specific Healthcare Costs Following Hospitalization for Heart Failure and Cost Offset with SGLT2 Inhibitor Therapy @AHAScience #GWTG_HF @mvaduganathan @gcfmd @DCRINews https://t.co/FBgBHgMvP4 https://t.co/rN1nFRsCbh https://t.co/mYJkdNbT8z
-
-
Mashup Score: 34Cause-Specific Healthcare Costs Following Hospitalization for Heart Failure and Cost Offset with SGLT2 Inhibitor Therapy: - 8 month(s) ago
ABSTRACTBackgroundLittle is known regarding differences in cause-specific costs between HF with EF≤40% versus >40%, and potential cost implications of SGLT2i therapy.ObjectivesTo compare cause-spec…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
Congratulations to @vkittipibul on #ACC24 #SimPub now in @JACCJournals #JACCHF Cause-Specific Healthcare Costs Following Hospitalization for Heart Failure and Cost Offset with SGLT2 Inhibitor Therapy @AHAScience #GWTG_HF @mvaduganathan @gcfmd @DCRINews https://t.co/FBgBHgMvP4 https://t.co/rN1nFRsCbh https://t.co/mYJkdNbT8z
-
RT @KPHeartDoc: One year as EiC of Heart Failure Reviews (https://t.co/yw6ZI3qrOb)—what a journey! 📈 1M+ views and an IF approaching 5 (top…